Low to moderate lifetime alcohol consumption is associated with less advanced stages of fibrosis in non-alcoholic fatty liver disease

Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes

(2016) Zobair M. Younossi et al.   HEPATOLOGY

Phosphatidylethanol Compared with Other Blood Tests as a Biomarker of Moderate Alcohol Consumption in Healthy Volunteers: A Prospective Randomized Study

(2015) Stergios Kechagias et al.   ALCOHOL AND ALCOHOLISM

Fibrosis Progression in Nonalcoholic Fatty Liver vs Nonalcoholic Steatohepatitis: A Systematic Review and Meta-analysis of Paired-Biopsy Studies

(2015) Siddharth Singh et al.   Clinical Gastroenterology and Hepatology

Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up

(2015) Mattias Ekstedt et al.   HEPATOLOGY

Validity of the Lifetime Drinking History: A Comparison of Retrospective and Prospective Quantity-Frequency Measures

(2015) Laura B. Koenig et al.   Journal of Studies on Alcohol and Drugs

Coffee, alcohol and other beverages in relation to cirrhosis mortality: The Singapore Chinese Health Study

(2014) George Boon-Bee Goh et al.   HEPATOLOGY

Utility and appropriateness of the fatty liver inhibition of progression (FLIP) algorithm and steatosis, activity, and fibrosis (SAF) score in the evaluation of biopsies of nonalcoholic fatty liver disease

(2014) Pierre Bedossa et al.   HEPATOLOGY

Modest alcohol consumption decreases the risk of non-alcoholic fatty liver disease: a meta-analysis of 43 175 individuals

(2013) Silvia Sookoian et al.   GUT

Effect of lifetime alcohol consumption on the histological severity of non-alcoholic fatty liver disease

(2013) Hellan K. Kwon et al.   LIVER INTERNATIONAL

Coffee consumption in NAFLD patients with lower insulin resistance is associated with lower risk of severe fibrosis

(2013) Kiran Bambha et al.   LIVER INTERNATIONAL

The global NAFLD epidemic

(2013) Rohit Loomba et al.   Nature Reviews Gastroenterology & Hepatology

NAFLD, NASH and liver cancer

(2013) Gregory A. Michelotti et al.   Nature Reviews Gastroenterology & Hepatology

Monitoring of the Alcohol Biomarkers PEth, CDT and EtG/EtS in an Outpatient Treatment Setting

(2012) Anders Helander et al.   ALCOHOL AND ALCOHOLISM

Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients

(2012) Pierre Bedossa et al.   HEPATOLOGY

Modest alcohol consumption is associated with decreased prevalence of steatohepatitis in patients with non-alcoholic fatty liver disease (NAFLD)

(2012) Winston Dunn et al.   JOURNAL OF HEPATOLOGY

Long term alcohol intake and risk of rheumatoid arthritis in women: a population based cohort study

(2012) D. Di Giuseppe et al.   BMJ-British Medical Journal

Effects of moderate red wine consumption on liver fat and blood lipids: a prospective randomized study

(2011) Stergios Kechagias et al.   ANNALS OF MEDICINE

The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis

(2010) Mustafa S. Ascha et al.   HEPATOLOGY

Soft drink consumption is associated with fatty liver disease independent of metabolic syndrome

(2009) Ali Abid et al.   JOURNAL OF HEPATOLOGY

Role of leisure-time physical activity in nonalcoholic fatty liver disease: A population-based study

(2008) Shira Zelber-Sagi et al.   HEPATOLOGY

Modest wine drinking and decreased prevalence of suspected nonalcoholic fatty liver disease

(2008) Winston Dunn et al.   HEPATOLOGY